
The S&P/ASX 200 Index (ASX: XJO) continued its recent slump on Monday. This included a heavy sell-off for many well-known ASX shares that hit fresh 52-week lows.
Three ASX shares hitting new yearly lows were:
- Brambles Ltd (ASX: BXB) crashed 20%
- Sonic Healthcare Ltd (ASX: SHL) dropped a further 2%
- Amcor Plc (ASX: AMC) fell 4%.
For investors holding positions in these companies, it can be difficult not to panic when shares hit 52-week lows.
For investors on the outside looking in, it can be an opportunity to find value in quality stocks.
Let’s see what experts are saying.
Brambles crashes on trading update
Brambles is the world’s largest supplier of reusable wooden pallets and crates used for storing and transporting goods.
It operates in more than 60 countries, primarily under the Chep brand. The company touts itself as a pioneer of the ‘sharing economy’, managing a reusable pool of pallets and containers to service global supply chains and logistics.
Yesterday, it released a FY26 trading update.
It revealed revised FY26 guidance and the announcement of a new US$400 million share buy-back.
Brambles now expects sales revenue growth of 2% to 3% (previously 3% to 4%) and underlying profit growth of 3% to 5% (from 8% to 11%).
This news sent investors running for the hills, as the share price crashed 20% to a new 52-week low of $17.63.
It may be a buy-low candidate after the crash.
The team at Jarden recently placed an overweight rating and $25.15 price target on Brambles shares.
It’s worth noting this was prior to the recent guidance downgrade.
Sonic Healthcare continues its slump
Sonic Healthcare is a global healthcare provider. It is the largest private medical laboratory and pathology services operator in Australia, the United Kingdom, Germany, and Switzerland.
It hit new 52-week lows yesterday closing at $18.39.
Its share price is now down 18% year to date.
It does have appeal as a dividend stock, as well as some capital upside.
16 analyst forecasts via TradingView place an average price target of $24.25 on this ASX healthcare stock.
That indicates roughly 30% upside from current levels.
Amcor continues to slide
Amcor operates as a holding company, which engages in the consumer packaging business.
It has struggled so far in 2026, falling 4% yesterday to take its year to date fall to roughly 18%.
It recently released 3Q26 earnings which were largely in line with expectations.
The team at Morgans is optimistic this ASX stock can bounce back from fresh 52-week lows.
The broker recently lowered its price target to $65.40 (from $68.20), however maintained its buy recommendation.
From yesterday’s closing price of $51.44, this updated target indicates an upside potential of 27%.
The post Should investors buy low on these ASX shares hitting 52-week lows? appeared first on The Motley Fool Australia.
Should you invest $1,000 in Brambles right now?
Before you buy Brambles shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Brambles wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Why A2 Milk, Brambles, Elders, and Tuas shares are sinking today
- Why is everyone talking about Elders, Brambles and New Hope shares on Monday?
- Why are Brambles shares crashing more than 15% to a new 12-month low today?
- Brambles revises FY26 outlook, announces new US$400m buy-back
- 5 ASX shares with upgraded ratings this week
Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Amcor Plc. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.